Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?

Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):e76-e79. doi: 10.1016/j.clinre.2017.03.006. Epub 2017 Apr 21.
No abstract available

Keywords: Hepatitis C virus; Sofosbuvir/ledipasvir; Tenofovir.

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Fluorenes / therapeutic use*
  • Hepatitis C / drug therapy*
  • Humans
  • Sofosbuvir / therapeutic use*
  • Tenofovir / therapeutic use*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Benzimidazoles
  • Fluorenes
  • ledipasvir
  • Tenofovir
  • Sofosbuvir